ABSTRACT
We report the engineering of poly(ethylene glycol) (PEG) hydrogel particles using a mesoporous silica (MS) templating method via tuning PEG molecular weight, particle size and the presence or absence of the template, and investigate the cell association and biodistribution of these particles. An ex vivo assay based on whole human blood that is more sensitive and relevant in vitro assays than traditional cell-line based assays for predicting in vivo circulation behavior is introduced. The association of MS@PEG particles (template present) with granulocytes and monocytes is higher compared with neat PEG particles (template absent). Increasing the PEG molecular weight (from 10 to 40 kDa) or decreasing the particle size (from 1400 to 150 nm) reduces phagocytic blood cell association of the PEG particles. Mice biodistribution studies show that the PEG particles exhibit extended circulation times (>12 h) compared with the MS@PEG particles and that the retention of smaller PEG particles (150 nm) in blood, when compared with larger PEG particles (>400 nm), is increased at least four-fold at 12 h after injection. Our findings highlight the influence of unique aspects of polymer hydrogel particles on biological interactions. The reported PEG hydrogel particles represent a new class of polymer carriers with potential biomedical applications.
The application of nanotechnology to drug delivery is widely expected to revolutionize the treatment of a range of diseases. [1] [2] [3] [4] [5] In recent years, nanoengineered polymer hydrogel particles have received interest as drug delivery systems because they can be fabricated through versatile techniques that provide precise control over the particle physiochemical properties and functionality. [6] [7] [8] Although important parameters have been investigated, such as the influence of particle size, shape, and elasticity on biological systems in vitro and in vivo, [9] [10] [11] it remains a challenge to control and predict the ability to avoid clearance by phagocytic blood cells before reaching the desired site of action. Poly(ethylene glycol) (PEG), an FDA-approved polymer that enhances surface hydrophilicity, and reduces association and uptake by phagocytes, is the most frequently used so-called "stealth" material for this application. [12] [13] [14] The stealth properties of PEGylated particles are usually dependent on the PEG chain architecture and PEG surface density, both of which are difficult to finely control and simulate. [15] [16] [17] [18] An alternative method to circumvent the issues relating to PEG chain architecture and PEG density is to use particles composed primarily of PEG.
Several approaches have been reported to generate PEG-based particles. DeSimone and coworkers recently developed a "PRINT" method for the preparation of PEG-based hydrogel particles with different shapes and sizes. 19, 20 The Doyle group reported micrometer-sized PEG-based particles with tunable size via a continuous-flow lithography method. [21] [22] [23] In addition, we introduced a strategy to produce PEG-based hydrogel particles via click-driven chemistry or surface-initiated polymerization within template particles. 24, 25 These PEG-based particles were prepared via polymerization of PEG diacrylate and/or PEG monomethacrylate.
Recently, we reported PEG particles solely composed of 8-arm-PEG with tunable elasticity via the mesoporous silica (MS) templating method, 26 which has proven to be a versatile method in the fabrication of polymer particles for drug and gene delivery because it allows precise control over size, shape, chemical composition, and elasticity, as well as cargo loading and release. [27] [28] [29] [30] [31] The deformability behavior of these particles in microchannels can be tailored to be similar to that of red blood cells (RBCs). While the reported approaches have shown their versatility to fabricate PEG particles on-demand, their detailed biological interactions (e.g., in vivo behavior) are largely unexplored. Therefore, it is important to engineer PEG particles with different physicochemical properties and examine their biological behavior to aid in the development of next-generation, long-circulating drug delivery systems.
Herein, we investigate the influence of the PEG molecular weight, particle size, and presence or absence of a template on phagocytic blood cell association and biodistribution of the particles (Figure 1) . To facilitate efficient PEG loading in the MS templates, 8-arm-PEG with amine functional groups (8-arm-PEG-NH 2 ) was used to infiltrate the MS templates exploiting electrostatic interactions. PEG particles were obtained by cross-linking the amine groups, followed by removal of the MS templates. Three different molecular weights (10, 20, or 40 kDa) of 8-arm-PEG-NH 2 were used as building blocks. The size of the PEG particles was tuned by varying the initial template diameters between 100 and 1000 nm (specifically 110, 280, 500 and 1000 nm). In addition, the free amine groups could be modified with functional moieties, such as fluorescent dyes to permit visualization of the particles for in vitro and ex vivo studies, or cage amine ligands capable of coordinating positronemitting 64 Cu for in vivo biodistribution studies. An understanding of biological interactions in vitro and in vivo is required for the design of stealthy drug carriers. In vitro experiments typically measure phagocyte association using cell lines to select promising candidates for in vivo studies. It is generally assumed that particles with lower cell association have extended circulation times. 32, 33 However, particles incubated with cell lines may behave differently to particles placed in more complex environments such as human tissue, human blood, or the circulatory system of animals. In this study, we incubated the particles with fresh, whole human blood at 37 °C to investigate phagocytic blood cell association, which predicts in vivo circulation behavior more accurately than traditional assays. We observed that increasing PEG molecular weight or decreasing particle size reduced phagocytic blood cell association of the PEG particles. MS@PEG particles resulted in higher blood cell association compared to their template-free PEG particles.
Similarly, biodistribution studies in mice showed that the PEG particles had superior in vivo circulation times (>12 h) compared with the MS@PEG particles and that smaller PEG particles (150 nm) resulted in higher blood retention and longer circulation times.
RESULTS AND DISCUSSION
For the construction of PEG particles, four different sizes of MS particles with average diameters of 1000, 500, 280, and 110 nm (denoted as MS-1000, MS-500, MS-280, and MS-110 particles, respectively) were synthesized. The three larger templates were synthesized using polyelectrolyte-surfactant complexes as dynamic templates according to a modified literature method. 34 The size control of the MS particles was controlled by varying the concentration of polyelectrolytes, where less polyelectrolyte resulted in a smaller particle diameter. 34 Smaller MS particles (110 nm) were synthesized using cetyltrimethylammonium tosylate as the templating surfactant and small organic amines (i.e., triethanolamine) as base. 35 The spherical morphology and porous structure of the MS particles are shown in the transmission electron microscopy (TEM) images (Figure 2a1-d1 ). For the fabrication of the PEG particles, 8-arm-PEG-NH 2 with a hexaglycerol core structure was infiltrated into the MS templates, driven by electrostatic interactions. 26 The amine groups of the 8-arm-PEG-NH 2 were then partially cross-linked with 8-arm-PEG functionalized with succinimidyl carboxyl methyl ester (8-arm-PEG-NHS, Figure S1a ), which resulted in MS@PEG particles. The were used as templates, respectively, and the PEG with a molecular weight of 40 kDa was used for particle fabrication. All of the particles were well dispersed in aqueous solution, showing homogeneous fluorescence, and swelling ~40% relative to their respective templates ( Table S1 ). Note that the fluorescence images of PEG40-110 particles were taken via immobilizing the particles in 2.5% agarose gel (low melting point) to prevent diffusion of the particles (Figure 2d2,d3 ). Zeta potential measurements showed that the PEG particles were ~15 mV in water, which indicates there are still free amine groups in the particles. However, the zeta potential became neutral at pH 7.4 in 10 mM phosphate buffer, which may be due to the hydrolysis of the N-hydroxysuccinimide (NHS) ester forming carboxylate groups during the cross-linking step and the charge screening by salt. Fourier transform infrared spectroscopy (FTIR) measurements proved the presence of carboxylate groups (1730 cm -1 ) in the PEG particles ( Figure S2 ). However, it was difficult to discern the N-H (3409 cm -1 ) peak for both 8-arm-PEG-NH 2 and PEG particles. Atomic force microscopy (AFM) measurements of the PEG particles showed that the PEG particles collapsed following air-drying, and that the thickness of the particles was just ~1/100 times the diameter of the PEG particles in aqueous solution (Figure 2a3-c3 and Table S1 ). This indicates that the PEG particles are highly hydrated in aqueous solution. TEM was also used to elucidate the structure of the PEG particles in the dry state, which shows that they dehydrate and spread on the copper grid (Figure 2a4-c4); this is consistent with the results of AFM measurements. Note that because of dehydration, the PEG40-110 nm particles could not be detected by AFM or TEM. For a comparison of the parameters governing particle formation, 8-arm-PEG-NH 2 with different molecular weights (10, 20, and 40 kDa) were used to assemble PEG particles (template diameter, 1000 nm). These particles are denoted as PEG10-1000, PEG20-1000, and PEG40-1000 particles, respectively. The thickness of the PEG particles after air-drying was lower when higher molecular weight PEG was used (Figure S3 ), which indicates that the PEG particles prepared with higher molecular weight PEG were more hydrated in aqueous solution. Because of the neutral charge and extensive hydration, the PEG particles were expected to exhibit stealth properties in biological systems. To investigate the stealth properties of the PEG particles, we first assessed the cell association of the MS@PEG and PEG particles using the THP-1 cell line, which is a human monocytic cell line commonly studied in phagocytosis assays. There was less cell association for the PEG particles compared to the corresponding MS@PEG particles (Figure S4) . Also, smaller MS@PEG40 particles resulted in less cell association, which may be due to differences in sedimentation and particle diffusion. 36 For the PEG particles, THP-1 cell association was less than 3% and the PEG particles prepared with higher molecular weight PEG (i.e., longer PEG arms) induced less cell association. This is most likely because of the increased hydration mentioned above and because longer PEG chains result in a thicker protective layer. 16 The low levels of association for the PEG particles precluded detecting significant differences between the cell associations of the smaller PEG particles (i.e., PEG40-500 and PEG40-280).
Monocytes and granulocytes play a major role in the elimination of pathogens, dead or dying cells, and foreign bodies in the blood. 37 This property can restrict the capacity of particles to reach target cells to deliver the payload. A human whole blood assay is therefore a more relevant model system to test the stealth properties of particles when compared to cell lines derived from one specific type of blood cell. To visualize the cell association of the PEG particles in whole blood, we labeled monocytes and granulocytes with fluorescent antibodies. After incubation with particles, cell association was observed using deconvolution microscopy ( Figure S5 ). Cell-associated particles were almost exclusively internalized by these professional phagocytes. PEG10-1000 particles were internalized by about 30% of monocytes and in low numbers (1-2 particles), while ~80% of monocytes contained MS@PEG10-1000 particles. Similar observations were made for granulocyte association, which inspired a more quantitative look at cell association in whole blood using flow cytometry.
Cell association was investigated for the PEG and MS@PEG particles with gated populations of monocytes and granulocytes using flow cytometry after incubating the particles in whole human blood for 1, 5 or 21 h (Figure S6) . In agreement with the results observed from the THP-1 cell association experiments, higher molecular weight PEG resulted in less cell association for PEG particles (Figure 3a) . We found that the monocyte association was higher than the granulocyte association for the same particles (p<0.001), although the effect of PEG molecular weight on particle association was the same for both cell populations. Compared with the PEG particles, the cell association of the MS@PEG particles was significantly higher (all above 50% after 1 h incubation, p<0.001). Increasing the incubation time to 5 h induced higher cell association for the PEG particles, although cell association remained low for PEG40-1000 particles. In comparison, almost all of the cells associated with the MS@PEG particles, regardless of the PEG molecular weight after 5 h incubation. Overall, there was much higher particle association with human blood phagocytes compared with the THP-1 cell line, which demonstrates that this is a more sensitive assay to detect reductions in phagocyte association for different particle compositions. On the basis of the results obtained above, we focused our study on the 40 kDa PEG, since higher molecular weight PEG resulted in less cell association for the PEG particles. To investigate the influence of the particle size on the cell association, PEG40 and MS@PEG40 with different sizes were incubated with human blood for 5 or 21 h. From Figure 3b , smaller PEG particles resulted in less cell association, a result that could not be concluded with confidence from the THP-1 cell association assay. For all sizes, the association for MS@PEG particles was much higher than that for the PEG particles (p<0.001). Except for the sedimentation effect, 36 this may be also because of the differences in elasticity of the obtained particles due to template removal, 38, 39 where MS@PEG particles with silica cores are almost incompressible, while PEG particles cross-linked with 2 mg mL -1 of cross-linker have a low Young's modulus of ~1.6 kPa. 26 Non-PEG polymer particles (thiolated poly(methacrylic acid), PMA SH , 10% modification), 40 were used as a control to check cell association. The different sizes of PMA SH had higher cell association in whole blood than similarly sized PEG particles (Figure S7) For in vivo studies, a macrobicyclic cage amine ligand was first conjugated to the particles by the reaction of amine groups and macrobicyclic cage amine ligand (1-CH 3 -8-NHCO(CH 2 ) 3 CO 2 -NHS) sarcophagine (MeCOSar-NHS) (Figure S1b) . Cage amine ligands of the sarcophagine (sar, 3,6,10,13,16,19-hexaaza-bicyclo[6.6.6]icosane) type form extremely stable and kinetically inert Cu II complexes. [41] [42] [43] The MS@PEG40 and PEG40 particles were further labeled with 64 Cu via incubation with 64 Cu solution in PBS at pH 7.2 for 30 min at room temperature. The particles were washed twice with PBS and resuspended in PBS buffer. Less than 0.1% of the initial 64 Cu amount was found in the second wash fraction, indicating efficient clean up. To examine the in vivo biodistribution of the particles, 5×10 8 radiolabeled particles were intravenously injected into each healthy C57BL/6 mouse.
The animals were sacrificed at different time points after intravenous injection, and the blood and organs were removed to measure the radioactivity level using a gamma-counter.
Distribution of PEG40-500 and PEG40-280 particles from blood to tissues occurred mostly in the first 30 min and the blood accumulation of these particles decreased to 10-15 %ID g -1 (Figure 4a,b) . Subsequently, 50% of the PEG40-500 particles were eliminated after 3 h and there was only 1.4 %ID g -1 left in the blood. However, it took about 12 h to eliminate 50% of the PEG40-280 particles, which indicates that the PEG40-280 particles circulate longer than the PEG40-500 particles. In comparison, the MS@PEG40-500 and MS@PEG40-280 particles were completely cleared from the blood less than 30 min after injection (data not shown), indicating that the PEG40 particles had extended in vivo circulation times compared with the MS@PEG particles. As shown in Figure 4a and 4b, except for retention in the blood, PEG particles mostly accumulated in the spleen and liver, since they are the mononuclear phagocytic systems (MPS) for clearing foreign blood-borne particulate entities. 44, 45 Positron emission tomography-computed tomography (PET/CT) imaging confirmed the biodistribution results, which revealed prominent uptake of MS@PEG40 particles and PEG40 particles in the liver and spleen 30 min post-injection, respectively (Figure 4c-f ). In addition, some PEG particles in the heart were observed (Figure 4e,f) , which is attributed to the heart containing a certain amount of blood at any given time and because there is some retention of PEG40 particles in the blood. mL of water at 80 °C. Then 3.9 mL of TEOS was quickly added into the surfactant solution.
The mixture was vigorously stirred at 80 °C for another 2 h. The synthesized MS particles were washed with water and ethanol, dried at 80 °C, and finally calcined at 550 °C for 6 h. 
Synthesis of (t-Boc

Synthesis of MeCOSar-NHS-ester.
To a solution of (t-Boc) [4] [5] MeCOSar-NHS-ester (0.023 g, 0.025 mmol) in dichloromethane (5 mL) was added trifluoroacetic acid (5 mL). The mixture was shaken at room temperature for 3 h. The solution was purged with N 2 to reduce the volume to 1 mL. Cold diethyl ether (45 mL) was added to precipitate a white solid.
Following centrifugation (3 min, 1000 g) the ether layer was removed by decanting and the procedure was repeated. Finally, the majority of the residual diethyl ether was removed in vacuo and the tris-trifluoroacetic acid tris-hydrate salt of the compound was isolated (0.017 g, 71% approx. yield based on four t-Boc groups). Fabrication of PMA SH Particles. PMA PDA was synthesized via EDC-mediated amide bond formation between the carboxyl groups of PMA and the amine groups of PDA. 28 and then quantified from a calibration curve of PDA, which corresponded to 10 mol% modification. PMA SH particles were fabricated via thiol-disulfide exchange cross-linking according to our previously published method. 39 The concentration of the cross-linker (PMA SH ) was 0.5 mg mL -1 .
THP-1 Cell Association. THP-1 cells (ATCC) were seeded in a 24-well plate (70 000 cells per well) in RPMI media with the addition of 10% (v/v) HI-FBS and incubated with AF488labeled MS@PEG or PEG particles at a particle-to-cell ratio of 100:1 for 24 h at 37 °C in a 5% CO 2 humidified atmosphere. After incubation, the cells were collected and washed with PBS three times via centrifugation at 400 g for 5 min. The resulting cell pellets were resuspended in PBS and analyzed by flow cytometry (Apogee Micro Flow Cytometer).
Blood Cell Association and Imaging. Whole blood from healthy volunteers was collected into Sodium Heparin Vacuette tubes (Greiner Bio-One). A single source of blood was used for flow cytometry and an alternate single source of blood for microscopy. Particles were incubated with 100 µL of blood at 37 ºC and 5% CO 2 for 1 or 5 h in 5 mL polystyrene tubes (BD Biosciences, San Jose, CA). The particle:leukocyte ratio was 100:1 for all experiments.
For flow cytometry, prior to particle incubation, leukocytes in whole blood were 
